Skip to main content
CERS
NASDAQ Life Sciences

Cerus Q4 Revenue Surpasses Estimates by 11%, Posts $2.2M Net Income

feedReported by Reuters
Sentiment info
Positive
Importance info
8
Price
$2.52
Mkt Cap
$485.981M
52W Low
$1.12
52W High
$2.955
Market data snapshot near publication time

summarizeSummary

Cerus Corp reported strong fourth-quarter results, with revenue reaching $64.6 million, significantly exceeding the IBES estimate of $58.1 million. The company also posted a net income of $2.2 million and adjusted EBITDA of $3.4 million, alongside a gross profit of $29.7 million. Furthermore, Cerus provided a full-year revenue outlook of $224-228 million. This positive earnings surprise and solid guidance are material for the stock, indicating better-than-expected operational performance and potentially driving investor confidence. Traders will likely react positively to the revenue beat and the profitable quarter.

At the time of this announcement, CERS was trading at $2.52 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $486M. The 52-week trading range was $1.12 to $2.96. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: Reuters.


show_chartPrice Chart

Share this article

Copied!

feed CERS - Latest Insights

CERS
Apr 22, 2026, 12:01 PM EDT
Filing Type: DEFA14A
Importance Score:
8
CERS
Apr 22, 2026, 12:00 PM EDT
Filing Type: DEF 14A
Importance Score:
8
CERS
Apr 21, 2026, 4:21 PM EDT
Filing Type: 8-K
Importance Score:
7
CERS
Mar 16, 2026, 5:18 PM EDT
Filing Type: 8-K
Importance Score:
8
CERS
Mar 02, 2026, 5:03 PM EST
Filing Type: 10-K
Importance Score:
7
CERS
Mar 02, 2026, 4:03 PM EST
Filing Type: 8-K
Importance Score:
7
CERS
Mar 02, 2026, 4:01 PM EST
Source: Reuters
Importance Score:
8
CERS
Jan 12, 2026, 8:06 AM EST
Filing Type: 8-K
Importance Score:
7